Teva Pharmaceutical Industries TEVA
NYSE TEVA
$36.68 -0.08 (-0.22%)
As of: Sep 9, 2026 · 12:52 PM EDT

Teva Pharmaceutical Industries (TEVA) EPS (Diluted) (2009 - 2026)

Analysis

Teva Pharmaceutical Industries (TEVA) EPS (Diluted) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Teva Pharmaceutical Industries 42.76 Bn 39.10 Bn 2.15 Bn -0.49
2 Viatris 19.19 Bn 18.30 Bn 1.46 Bn -0.10
3 Dr Reddys Laboratories 9.85 Bn 9.68 Bn 396.53 Mn 0.06
4 Amneal Pharmaceuticals 5.52 Bn 5.39 Bn 334.51 Mn 0.21
5 Bausch Health Companies 2.38 Bn 545.13 Mn 2.10 Bn 0.69
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -0.23
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 1.13
8 Amphastar Pharmaceuticals 992.46 Mn 702.34 Mn 93.47 Mn 0.69
9 Fennec Pharmaceuticals 409.53 Mn 368.28 Mn 17.15 Mn 0.05
10 RedHill Biopharma 179.80 Mn 179.80 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.49
Mar 31, 2026 0.31
Dec 31, 2025 0.40
Sep 30, 2025 0.37
Jun 30, 2025 0.24
Mar 31, 2025 0.19
Dec 31, 2024 -0.24
Sep 30, 2024 -0.35
Jun 30, 2024 -0.77
Mar 31, 2024 0.46
Dec 31, 2023 0.42
Sep 30, 2023 0.07
Jun 30, 2023 -0.81
Mar 31, 2023 -0.23
Dec 31, 2022 -1.20
Sep 30, 2022 0.06
Jun 30, 2022 -0.25
Mar 31, 2022 -0.88
Dec 31, 2021 -0.14
Sep 30, 2021 0.28